VivoSim Labs, Inc. (VIVS)
NASDAQ · Healthcare
VivoSim Labs, Inc. Shareholder Equity 2010–2025
VivoSim Labs, Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- VivoSim Labs, Inc. shareholder equity as of March 31, 2025: 10.5M, a 191.36% increase year-over-year.
- VivoSim Labs, Inc. shareholder equity for 2025 were 10.5M, a 191.36% increase from 2024.
- VivoSim Labs, Inc. shareholder equity for 2024 were 3.6M, a 76.51% decrease from 2023.
- VivoSim Labs, Inc. shareholder equity for 2023 were 15.3M, a 49.26% decrease from 2022.
- VivoSim Labs, Inc. shareholder equity for 2022 were 30.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| VivoSim Labs, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $10 |
| 2024 | $4 |
| 2023 | $15 |
| 2022 | $30 |
| 2021 | $39 |
| 2020 | $27 |
| 2019 | $36 |
| 2018 | $45 |
| 2017 | $62 |
| 2016 | $62 |
| 2015 | $49 |
| 2014 | $48 |
| 2012 | $-5 |
| 2011 | $-2 |
VivoSim Labs, Inc. Shareholder Equity — FAQ
VivoSim Labs, Inc. (VIVS) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VIVS's shareholder equity history?
The chart and table above show VivoSim Labs, Inc.'s shareholder equity by year and by quarter, including the growth rate.